TransCode Therapeutics Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| YORKVILLE ADVISORS GLOBAL, LP | 08/06/2026 | 19.64 K | $121.96 K | 100.00% | 2.10% |
| VANGUARD CAPITAL MANAGEMENT LLC | 08/13/2026 | 6.55 K | $40.64 K | 0.00% | 0.70% |
| VANGUARD FIDUCIARY TRUST CO | 08/13/2026 | 2.98 K | $18.52 K | 0.00% | 0.32% |
| UBS GROUP AG | 08/13/2026 | 2.89 K | $17.93 K | -65.18% | 0.31% |
| MERCER GLOBAL ADVISORS INC /ADV | 08/11/2026 | 1.54 K | $9.53 K | 100.00% | 0.16% |
| FMR LLC | 08/13/2026 | 706 | $4.38 K | 100.00% | 0.08% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 08/11/2026 | 677 | $4.20 K | 196.93% | 0.07% |
| WELLS FARGO & COMPANY/MN | 08/14/2026 | 55 | $342 | 0.00% | 0.01% |
| SBI SECURITIES CO., LTD. | 07/23/2026 | 12 | $75 | 0.00% | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 08/12/2026 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
TransCode Therapeutics Inc institutional Ownership - FAQ's
During the previous two years, 12 institutional investors and hedge funds held shares of TransCode Therapeutics Inc. The most heavily invested institutionals were:
Yorkville Advisors Global, LP: 19,639
VANGUARD CAPITAL MANAGEMENT LLC: 6,545
VANGUARD FIDUCIARY TRUST CO: 2,982
UBS Group AG: 2,888
MERCER GLOBAL ADVISORS INC /ADV: 1,535
FMR LLC: 706
3.74% of TransCode Therapeutics Inc stock is owned by institutional investors.
Institutional investors have bought a total of 35.04 K shares in the last 24 months. This purchase volume represents approximately $338.83 K in transactions.